Posted on April 24, 2009 by cartier@bio
Josh Green, general partner at MDV-Mohr Davidow Ventures and three entrepreneurs visited Capitol Hill on Wednesday to testify before the House Small Business Committee about the need to reauthorize the SBIR program.
The Wall Street Journal’s Venture Capital Dispatch blog reported,
“Companies receiving venture funding may have other innovation in the pipeline worth [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, House Small Business Committee, SBIR, venture capital | 1 Comment »
Posted on March 31, 2009 by cartier@bio
With Congress knee-deep in legislation to help stimulate the economy and arguing over the budget, things are starting to heat up for Small Business Innovation Research (SBIR) as well. The current credit crunch has made obtaining funding for biomedical research even tougher. Researchers are facing unprecedented challenges. Unfortunately for some in biotech, slow cash flow [...]
Filed under: BIO, Congress, In the News, SBIR | Tagged: Alzheimer's, Barack Obama, Congress, NIH, Patent Baristas, SBIR | Leave a Comment »
Posted on September 25, 2008 by cartier@bio
The Parkinson’s Action Network sent this to us for our blog:
The Parkinson’s Action Network and RetireSafe, along with 58 other organizations sent a letter to Congress urging them to take action on the SBIR Reauthorization Act this Congressional session. The Parkinson’s Action Network recognizes the unique needs of small biotechnology companies and that shrinking the [...]
Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, Parkinson's Action Network, SBIR | Leave a Comment »
Posted on September 2, 2008 by cartier@bio
On August 22, The Boston Globe ran an editorial discussing the SBIR bill created by Senator Kennedy, stating:
Kennedy and Rudman created the program because the work of small companies was often considered too risky and too preliminary to attract venture capital money. Supporters of the program fear that the House bill will dampen the kind [...]
Filed under: Congress, In the News, SBIR, venture capital | Tagged: Congress, SBIR, Senator Kennedy | 1 Comment »
Posted on May 9, 2008 by cartier@bio
Washington Business Journal
The House passed legislation that would make small businesses majority-owned by venture capital firms eligible for Small Business Innovation Research awards.
Through the SBIR program, 2.5 percent of the outside research budgets of 11 federal agencies — including the Department of Defense and the National Institutes of Health — is allocated for small [...]
Filed under: Congress, In the News, SBIR, Uncategorized | Tagged: Congress, NIH, SBIR, small business innovation, Washington Business Journal | Leave a Comment »
Posted on May 6, 2008 by cartier@bio
The National Dialogue on Entrepreneurship is following the SBIR Debate:
SBIR Bill Advances
A new proposal to reauthorize and modernize the Small Business Innovation Research (SBIR) program is making fast progress through Congress. Late last month, the House of Representatives overwhelmingly passed H.R. 5819, a bill to reauthorize the SBIR program—which directs federal research funds [...]
Filed under: In the News, SBIR, venture capital | Tagged: Congress, HR 5819, Phase I, SBIR, Technology | Leave a Comment »
Posted on April 25, 2008 by cartier@bio
The Cystic Fibrosis Foundation today lauded the U.S. House of Representatives for passing legislation to reauthorize the Small Business Innovation Research (SBIR) program.
In response to testimony from Robert J. Beall, Ph.D., president and CEO of the Foundation, the legislation includes a provision requiring that special attention be given to research for rare diseases, such as [...]
Filed under: Congress, SBIR, patient groups | Tagged: Congress, cystic fibrosis, SBIR | 1 Comment »
Posted on March 25, 2008 by cartier@bio
The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. We spoke with Mary Dwight about her organization and the important work they do.
Can you tell us a bit about CFF’s purpose? The Cystic Fibrosis Foundation is the leader in developing drugs to treat and [...]
Filed under: Congress, Finding Cures, SBIR, patient groups | Tagged: Congress, cystic fibrosis, patient groups, SBIR | 3 Comments »
Posted on March 24, 2008 by cartier@bio
House Small Business Committee Holds Hearing on the Reauthorization of the Small Business Innovation Research Program
Witness List
March 13, 2008
Chairwoman Velazquez’s (NY-12) led a lively hearing on the SBIR program in helping small businesses support promising research. She emphasized the importance of reinstating eligibility of majority venture capital-backed companies and highlighted the remedy offered in the [...]
Filed under: Congress, SBIR | Tagged: BIO, Congress, SBIR, venture capital | Leave a Comment »
Posted on March 7, 2008 by cartier@bio
Putting the “I” back — that is the “I” in innovation. While we consider SBIR program to be critical to the commercialization of biotechnology for our industry, it is clear that others do not share this view ordiffer on the ways in which this problem should be fixed. For example, Kristie Prinz wrote [...]
Filed under: Finding Cures | Tagged: biotechnology, Congress, Innovation, National Research Council, NIH, SBIR | Leave a Comment »
